Last 12 months
Inside the activity.
1 purchase rows · 24 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 2 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2021 Filed Mar 12, 2021 22:29 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,000 | $47.20 | $47,200.00 |
DisclosureSEC source: 0001179110-21-003376 · edgar.xml · nonDerivative · entry 2 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 415,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.80 to $47.69 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 22:29 UTC |
Payson NormanDirector
|
SaleCommon Stock | 4,000 | $46.12 | $184,480.00 |
DisclosureSEC source: 0001179110-21-003376 · edgar.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 416,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.74 to $46.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and 5. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| March 10, 2021 Filed Mar 13, 2021 01:01 UTC |
Schlanger David JChief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,003 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-003392 · edgar.xml · derivative · entry 8 Schlanger David J · CIK 0001576145 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,571,381 Underlying: Common Stock · 13,003 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 10, 2021 Filed Mar 13, 2021 01:01 UTC |
Schlanger David JChief Executive Officer
|
SaleCommon Stock | 13,003 | $47.50 | $617,642.50 |
DisclosureSEC source: 0001179110-21-003392 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.23 to $47.94 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in in footnotes (2) and (3). Read SEC document |
| March 10, 2021 Filed Mar 13, 2021 01:01 UTC |
Schlanger David JChief Executive Officer
|
Exercise / conversionCommon Stock | 13,003 | $0.91 | $11,832.73 |
DisclosureSEC source: 0001179110-21-003392 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 22:49 UTC |
Anevski PeterPresident and COO
|
SaleCommon Stock | 8,999 | $47.43 | $426,822.57 |
DisclosureSEC source: 0001179110-21-003378 · edgar.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · See footenote Disclosed balance after: 159,001 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on September 3, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.23 to $47.95 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4). F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 22:51 UTC |
Livingston Mark S.Chief Financial Officer
|
Tax withholdingCommon Stock | 345 | $42.17 | $14,548.65 |
DisclosureSEC source: 0001179110-21-003268 · edgar.xml · nonDerivative · entry 1 Livingston Mark S. · CIK 0001824161 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,409 F1 · shares: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the reporting person on March 9, 2020. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 22:21 UTC |
Greenbaum LisaEVP, Chief Client Officer
|
Tax withholdingCommon Stock | 298 | $42.17 | $12,566.66 |
DisclosureSEC source: 0001179110-21-003267 · edgar.xml · nonDerivative · entry 1 Greenbaum Lisa · CIK 0001791866 · EVP, Chief Client Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,746 F1 · shares: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the reporting person on March 9, 2020. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 23:20 UTC |
Payson NormanDirector
|
SaleCommon Stock | 200 | $43.01 | $8,602.00 |
DisclosureSEC source: 0001179110-21-003017 · edgar.xml · nonDerivative · entry 6 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 420,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.99 to $43.05 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 23:20 UTC |
Payson NormanDirector
|
SaleCommon Stock | 860 | $42.46 | $36,515.60 |
DisclosureSEC source: 0001179110-21-003017 · edgar.xml · nonDerivative · entry 5 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 420,200 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.96 to $42.91 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 23:20 UTC |
Payson NormanDirector
|
SaleCommon Stock | 2,300 | $41.37 | $95,151.00 |
DisclosureSEC source: 0001179110-21-003017 · edgar.xml · nonDerivative · entry 4 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 421,060 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.965 to $41.93 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 23:20 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,640 | $40.60 | $66,584.00 |
DisclosureSEC source: 0001179110-21-003017 · edgar.xml · nonDerivative · entry 3 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 423,360 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.96 to $40.92 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:19 UTC |
Bealer JenniferEVP, General Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $42.78 | $0.00 |
DisclosureSEC source: 0001179110-21-002980 · edgar.xml · derivative · entry 2 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-03-02 F2 · derivative.exercise_date: Represents an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the Option vest on February 26, 2022, and the remaining shares subject to the Option vest in equal quarterly installments thereafter through February 26, 2025, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:19 UTC |
Bealer JenniferEVP, General Counsel
|
GrantCommon Stock | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002980 · edgar.xml · nonDerivative · entry 1 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,773 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the RSUs vest on February 26, 2022, and the remaining RSUs vest in equal quarterly installments thereafter through February 26, 2025, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 23:20 UTC |
Payson NormanDirector
|
SaleCommon Stock | 400 | $43.43 | $17,372.00 |
DisclosureSEC source: 0001179110-21-003017 · edgar.xml · nonDerivative · entry 2 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 425,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.33 to $43.53 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 23:20 UTC |
Payson NormanDirector
|
SaleCommon Stock | 4,600 | $42.87 | $197,202.00 |
DisclosureSEC source: 0001179110-21-003017 · edgar.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 425,400 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.31 to $43.295, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8). F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 23:15 UTC |
Livingston Mark S.Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $42.78 | $0.00 |
DisclosureSEC source: 0001179110-21-003014 · edgar.xml · derivative · entry 2 Livingston Mark S. · CIK 0001824161 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-03-02 F2 · derivative.exercise_date: Represents an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the Option vest on February 26, 2022, and the remaining shares subject to the Option vest in equal quarterly installments thereafter through February 26, 2025, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 23:15 UTC |
Livingston Mark S.Chief Financial Officer
|
GrantCommon Stock | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-003014 · edgar.xml · nonDerivative · entry 1 Livingston Mark S. · CIK 0001824161 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,754 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the RSUs vest on February 26, 2022, and the remaining RSUs vest in equal quarterly installments thereafter through February 26, 2025, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:31 UTC |
Greenbaum LisaEVP, Chief Client Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $42.78 | $0.00 |
DisclosureSEC source: 0001179110-21-002992 · edgar.xml · derivative · entry 2 Greenbaum Lisa · CIK 0001791866 · EVP, Chief Client Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-03-02 F2 · derivative.exercise_date: Represents an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the Option vest on February 26, 2022, and the remaining shares subject to the Option vest in equal quarterly installments thereafter through February 26, 2025, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:31 UTC |
Greenbaum LisaEVP, Chief Client Officer
|
GrantCommon Stock | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002992 · edgar.xml · nonDerivative · entry 1 Greenbaum Lisa · CIK 0001791866 · EVP, Chief Client Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,044 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the RSUs vest on February 26, 2022, and the remaining RSUs vest in equal quarterly installments thereafter through February 26, 2025, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:08 UTC |
Bealer JenniferEVP, General Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,292 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-002821 · edgar.xml · derivative · entry 2 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,334 Underlying: Common Stock · 2,292 shares Expires 2027-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on October 30, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each monththereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:08 UTC |
Bealer JenniferEVP, General Counsel
|
Exercise / conversionCommon Stock | 2,292 | $0.91 | $2,085.72 |
DisclosureSEC source: 0001179110-21-002821 · edgar.xml · nonDerivative · entry 1 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,773 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 22:25 UTC |
Payson NormanDirector
|
SaleCommon Stock | 400 | $49.76 | $19,904.00 |
DisclosureSEC source: 0001179110-21-002363 · edgar.xml · nonDerivative · entry 8 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 430,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.60 to $50.00 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 22:25 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,675 | $48.71 | $81,589.25 |
DisclosureSEC source: 0001179110-21-002363 · edgar.xml · nonDerivative · entry 7 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 430,400 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.10 to $49.08 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 22:25 UTC |
Payson NormanDirector
|
SaleCommon Stock | 300 | $47.24 | $14,172.00 |
DisclosureSEC source: 0001179110-21-002363 · edgar.xml · nonDerivative · entry 6 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 432,075 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.03 to $47.60 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 22:25 UTC |
Payson NormanDirector
|
SaleCommon Stock | 900 | $45.84 | $41,256.00 |
DisclosureSEC source: 0001179110-21-002363 · edgar.xml · nonDerivative · entry 5 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 432,375 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.44 to $46.255 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 22:25 UTC |
Payson NormanDirector
|
SaleCommon Stock | 500 | $44.61 | $22,305.00 |
DisclosureSEC source: 0001179110-21-002363 · edgar.xml · nonDerivative · entry 4 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 433,275 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.24 to $44.975 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 22:25 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,225 | $43.64 | $53,459.00 |
DisclosureSEC source: 0001179110-21-002363 · edgar.xml · nonDerivative · entry 3 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 433,775 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.24 to $44.18 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:25 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,441 | $53.20 | $76,661.20 |
DisclosureSEC source: 0001179110-21-002363 · edgar.xml · nonDerivative · entry 2 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 435,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.07 to $53.40 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:25 UTC |
Payson NormanDirector
|
SaleCommon Stock | 3,559 | $52.51 | $186,883.09 |
DisclosureSEC source: 0001179110-21-002363 · edgar.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 436,441 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.075 to $52.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7), (8), (9), and (10). F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 18:06 UTC |
Bealer JenniferEVP, General Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,437 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001179110-21-002286 · edgar.xml · derivative · entry 6 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,814 Underlying: Common Stock · 3,437 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Adjusted due to rounding error. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 18:06 UTC |
Bealer JenniferEVP, General Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 632 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001179110-21-002286 · edgar.xml · derivative · entry 5 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,813 Underlying: Common Stock · 632 shares Expires 2029-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Adjusted due to rounding error. F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on March 20, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 18:06 UTC |
Bealer JenniferEVP, General Counsel
|
SaleCommon Stock | 2,472 | $49.76 | $123,006.72 |
DisclosureSEC source: 0001179110-21-002286 · edgar.xml · nonDerivative · entry 4 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,481 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 18, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.568 to $49.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 18:06 UTC |
Bealer JenniferEVP, General Counsel
|
Tax withholdingCommon Stock | 1,348 | $49.80 | $67,130.40 |
DisclosureSEC source: 0001179110-21-002286 · edgar.xml · nonDerivative · entry 3 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,953 Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 18:06 UTC |
Bealer JenniferEVP, General Counsel
|
Tax withholdingCommon Stock | 249 | $49.54 | $12,335.46 |
DisclosureSEC source: 0001179110-21-002286 · edgar.xml · nonDerivative · entry 2 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,301 Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 18:06 UTC |
Bealer JenniferEVP, General Counsel
|
Exercise / conversionCommon Stock | 4,069 | $3.95 | $16,072.55 |
DisclosureSEC source: 0001179110-21-002286 · edgar.xml · nonDerivative · entry 1 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Adjusted due to rounding error. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:22 UTC |
Payson NormanDirector
|
SaleCommon Stock | 2,298 | $49.17 | $112,992.66 |
DisclosureSEC source: 0001179110-21-001989 · edgar.xml · nonDerivative · entry 4 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 440,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.01 to $49.58 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust ("NMP Trust"). Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:22 UTC |
Payson NormanDirector
|
SaleCommon Stock | 2,702 | $48.72 | $131,641.44 |
DisclosureSEC source: 0001179110-21-001989 · edgar.xml · nonDerivative · entry 3 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 442,298 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.01 to $49.00 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust ("NMP Trust"). Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 21:22 UTC |
Payson NormanDirector
|
SaleCommon Stock | 623 | $49.78 | $31,012.94 |
DisclosureSEC source: 0001179110-21-001989 · edgar.xml · nonDerivative · entry 2 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 445,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.66 to $49.845 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust ("NMP Trust"). Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 21:22 UTC |
Payson NormanDirector
|
SaleCommon Stock | 4,377 | $49.16 | $215,173.32 |
DisclosureSEC source: 0001179110-21-001989 · edgar.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 445,623 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.63 to $49.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), and (6). F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust ("NMP Trust"). Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 20:58 UTC |
Bealer JenniferEVP, General Counsel
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,875 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001104659-21-025400 · tm217222-1_4seq1.xml · derivative · entry 2 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,626 Underlying: Common Stock · 6,875 shares Expires 2027-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on October 30, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 20:58 UTC |
Bealer JenniferEVP, General Counsel
|
Exercise / conversionCommon Stock | 6,875 | $0.91 | $6,256.25 |
DisclosureSEC source: 0001104659-21-025400 · tm217222-1_4seq1.xml · nonDerivative · entry 1 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:53 UTC |
Greenbaum LisaEVP, Chief Client Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001104659-21-025434 · tm217222-2_4seq1.xml · derivative · entry 4 Greenbaum Lisa · CIK 0001791866 · EVP, Chief Client Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,002 Underlying: Common Stock · 5,000 shares Expires 2029-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Adjusted due to rounding error. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option shall vest on June 3, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:53 UTC |
Greenbaum LisaEVP, Chief Client Officer
|
SaleCommon Stock | 3,046 | $51.00 | $155,346.00 |
DisclosureSEC source: 0001104659-21-025434 · tm217222-2_4seq1.xml · nonDerivative · entry 3 Greenbaum Lisa · CIK 0001791866 · EVP, Chief Client Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,044 F3 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ 50.91 to 51.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:53 UTC |
Greenbaum LisaEVP, Chief Client Officer
|
Tax withholdingCommon Stock | 1,954 | $51.29 | $100,220.66 |
DisclosureSEC source: 0001104659-21-025434 · tm217222-2_4seq1.xml · nonDerivative · entry 2 Greenbaum Lisa · CIK 0001791866 · EVP, Chief Client Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,090 F2 · price: The price reported in Column 4 is a weighted average price. These shares were withheld in several transactions at prices ranging from $51.29 to $51.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares withheld at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:53 UTC |
Greenbaum LisaEVP, Chief Client Officer
|
Exercise / conversionCommon Stock | 5,000 | $3.95 | $19,750.00 |
DisclosureSEC source: 0001104659-21-025434 · tm217222-2_4seq1.xml · nonDerivative · entry 1 Greenbaum Lisa · CIK 0001791866 · EVP, Chief Client Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Adjusted due to rounding error. Read SEC document |
| February 11, 2021 Filed Feb 12, 2021 21:34 UTC |
Payson NormanDirector
|
SaleCommon Stock | 665 | $50.87 | $33,828.55 |
DisclosureSEC source: 0001104659-21-021999 · tm216592-1_4seq1.xml · nonDerivative · entry 6 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 450,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.70 to $51.03 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust ("NMP Trust"). Read SEC document |
| February 11, 2021 Filed Feb 12, 2021 21:34 UTC |
Payson NormanDirector
|
SaleCommon Stock | 3,725 | $50.06 | $186,473.50 |
DisclosureSEC source: 0001104659-21-021999 · tm216592-1_4seq1.xml · nonDerivative · entry 5 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 450,665 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.655 to $50.49 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust ("NMP Trust"). Read SEC document |
| February 11, 2021 Filed Feb 12, 2021 21:34 UTC |
Payson NormanDirector
|
SaleCommon Stock | 610 | $49.17 | $29,993.70 |
DisclosureSEC source: 0001104659-21-021999 · tm216592-1_4seq1.xml · nonDerivative · entry 4 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 454,390 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.61 to $49.52 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust ("NMP Trust"). Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 21:34 UTC |
Payson NormanDirector
|
SaleCommon Stock | 900 | $50.81 | $45,729.00 |
DisclosureSEC source: 0001104659-21-021999 · tm216592-1_4seq1.xml · nonDerivative · entry 3 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 455,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.47 to $51.01 inclusive. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust ("NMP Trust"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.